Back
Aurinia Pharmaceuticals Vs. Acasti Pharma Industry Stock Comparison
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
5.79
Seasonality Move:
0.65%
Buy
61
ACST
Acasti Pharma
Last Price:
2.64
Seasonality Move:
15.72%
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.76. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.69. The Score for ACST is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ACST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 69.62 | Buy |
Chaikin Money Flow: | 518324 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.9 - 5.34) | Buy |
Bollinger Bands (100): | (4.84 - 7.76) | Sell |
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 35.69 | Sell |
Chaikin Money Flow: | -15108 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.72 - 3.08) | Sell |
Bollinger Bands (100): | (2.58 - 3.36) | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.3 | Buy |
20-day SMA: | 5.16 | Buy |
50-day SMA: | 5.12 | Buy |
200-day SMA: | 7.44 | Sell |
8-day EMA: | 5.4 | Buy |
20-day EMA: | 5.23 | Buy |
50-day EMA: | 5.41 | Buy |
200-day EMA: | 7.07 | Sell |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.76 | Sell |
20-day SMA: | 2.83 | Sell |
50-day SMA: | 3.15 | Sell |
200-day SMA: | 2.63 | Buy |
8-day EMA: | 2.76 | Sell |
20-day EMA: | 2.87 | Sell |
50-day EMA: | 2.99 | Sell |
200-day EMA: | 2.91 | Sell |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
Aurinia Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Acasti Pharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |